Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | October 16, 2023 01:31pm

Gainers

  • Tempest Therapeutics (NASDAQ:TPST) shares increased by 94.8% to $7.09 during Monday's regular session. Tempest Therapeutics's stock is trading at a volume of 107.5 million shares as of 13:30 EST. This is 2416.7% of its average full-day volume over the last 100 days. The company's market cap stands at $94.4 million.
  • Redhill Biopharma (NASDAQ:RDHL) shares rose 34.43% to $0.43. Trading volume for Redhill Biopharma's stock is 15.2 million as of 13:30 EST. This is 1823.6% of its average full-day volume over the last 100 days. The company's market cap stands at $2.5 million.
  • Processa Pharma (NASDAQ:PCSA) stock increased by 31.45% to $0.63. As of 13:30 EST, this security is trading at a volume of 64.8 million shares, making up 16575.5% of its average full-day volume over the last 100 days. The company's market cap stands at $15.5 million.
  • Mereo BioPharma Group (NASDAQ:MREO) stock rose 30.19% to $1.68. As of 13:30 EST, this security is trading at a volume of 17.1 million shares, making up 2011.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $235.5 million.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 23.73% to $2.45. Trading volume for Rani Therapeutics Hldgs's stock is 140.7K as of 13:30 EST. This is 325.4% of its average full-day volume over the last 100 days. The company's market cap stands at $62.5 million.
  • Modular Medical (NASDAQ:MODD) shares rose 22.82% to $1.13. The company's market cap stands at $23.8 million.

Losers

  • Streamline Health Solns (NASDAQ:STRM) shares declined by 67.0% to $0.24 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 2.6 million shares, making up 2236.8% of its average full-day volume over the last 100 days. The company's market cap stands at $14.3 million.
  • Aldeyra Therapeutics (NASDAQ:ALDX) shares declined by 66.12% to $1.84. As of 13:30 EST, this security is trading at a volume of 18.5 million shares, making up 3344.6% of its average full-day volume over the last 100 days. The company's market cap stands at $107.8 million.
  • Biocept (NASDAQ:BIOC) shares fell 49.03% to $0.52. Biocept's stock is trading at a volume of 1.3 million shares as of 13:30 EST. This is 73.6% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 million.
  • Ambrx Biopharma (NASDAQ:AMAM) stock declined by 30.75% to $9.73. Trading volume for this security as of 13:30 EST is 6.7 million, which is 1516.3% of its average full-day volume over the last 100 days.
  • Omeros (NASDAQ:OMER) stock decreased by 30.4% to $1.58. Trading volume for Omeros's stock is 6.1 million as of 13:30 EST. This is 1368.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $99.3 million.
  • Nexalin Technology (NASDAQ:NXL) shares declined by 27.6% to $0.34. The current volume of 801.7K shares is 3475.6% of Nexalin Technology's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $2.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALDX AMAM BIOC MODD MREO NXL OMER PCSA RANI RDHL STRM TPST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist